There is a newer version
of
this Section
2017 Kansas Statutes
Chapter 65 PUBLIC HEALTH
Article 6b AMYGDALIN (LAETRILE)
65-6b04 Same; act not endorsement; certain treatment by physician not prohibited.
Universal Citation: KS Stat § 65-6b04 (2017)
65-6b04. Same; act not endorsement; certain treatment by physician not prohibited. Nothing in this act shall be construed as constituting an endorsement of amygdalin (laetrile) for the treatment of any malignancy, disease, illness or physical condition, and nothing in this act shall be construed as preventing a physician from prescribing amygdalin (laetrile) as a dietary supplement to a patient not suffering from any known malignancy, disease, illness, or physical condition upon execution of the written informed request therefor.
History: L. 1978, ch. 239, § 4; July 1.
Disclaimer: These codes may not be the most recent version. Kansas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
